Commissions
Navigation Links
Commissions in Medical News
BTIG To Hold 7th Commissions for Charity Day
anticipated donationS to benefit local charities NEW YORK, May 18 /PRNewswire/ -- BTIG LLC, an institutional broker dealer specializing in trading and related brokerage services, will donate equity and derivative trading commission profits earned on Tuesday, May 19 to a group of nonprofit or...AHIP Statement on New CMS Guidelines for Agent and Broker Commissions in Medicare Advantage
WASHINGTON, Nov. 10 /PRNewswire-USNewswire/ -- Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP), today issued the following statement on new guidelines announced by CMS on agent and broker compensation for Medicare Advantage plans: "We commend CMS for taking this i...SAFC Pharma Commissions HPAPI Conjugates Facility at St. Louis
ST. LOUIS, Sept. 29 /PRNewswire-FirstCall/ -- SAFC Pharma(TM), a focus area within SAFC(R), a member of the Sigma-Aldrich Group (Nasdaq: SIAL ), today announced details of a new suite that has been commissioned at its St. Louis campus that will produce high-potency active pharmaceutical ingre...ATLANTA, June 3 /PRNewswire/ -- Physicians at California's San Antonio Community Hospital in Upland, will soon treat patients using the new Leksell(R) Gamma Knife Perfexion(TM). A revolutionary alternative to traditional open-brain surgery and daily radiation treatments, Leksell Gamma Knife Pe...
Chiefs Of Regional Commissions For Animal Health Announced
Dr. Robert Thwala, the Ministry of Agriculture Director of Veterinary and Livestock Services, was anointed as President of the African Regional Commission //for the International Committee of the World Organisation for Animal Health (OIE). Dr. Barry O’Neil was earlier elected the President of...MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
...fering of 3,500,000 shares of its common stock at a public offering price of $9.70 per share. Net proceeds, after estimated underwriting discounts and commissions and estimated expenses, will be approximately $31.4 million. MAP Pharmaceuticals has granted the underwriters of the offering a 30-day option to purc...NHP Reports 2009 Second Quarter Results
...ation 756 777 1,570 1,524 Lease commissions and tenant and capital improvements (1,343) (1,047) ... Deferred finance cost amortization 3,120 3,120 Lease commissions and tenant and capital improvements (5,608) (5,...West Announces Second Quarter 2009 Results
... increase included additional spending on information systems, including depreciation and other project-related costs, and outside services, including commissions and acquisition-related legal services. Research spending was substantially unchanged from the prior-year quarter. Resulting operating profit was $34...Hospira Reports Second-Quarter 2009 Results
... $402.0 $338.3 Trade accounts payable 200.4 231.5 Salaries, wages and commissions 121.2 144.7 Deferred income taxes - 1.5 Other accrued liabilities ...Cell Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Warrants
... overallotment option. The Company received approximately $40.3 million in net proceeds from the offering, after deducting underwriting discounts and commissions and estimated offering expenses. Each warrant has an exercise price of $1.70 per warrant share, for total potential additional gross proceeds t...Commissions in Medical Technology
...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...
...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...
...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue relian...
...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue relian...
... and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...
...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...
Breast Cancer Clinical Results Show Test Can Differentiate Normal, Early and Later Stage Cancers
...on for our products or product candidates. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward......rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue relian...
...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue relian...
PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate
... for our products or product candidates. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...... and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...
U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue relian...Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
...ly market products, and other factors which may be beyond the control of either Transition or Lilly. Please see Transition's filings with the Canadian commissions and Lilly's filings with the U.S. Securities and Exchange Commission for further information about risk factors and other cautionary statements. Neith...Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
...n Stock at a price of $0.65 per share resulting in gross proceeds of $650,000. WestPark Capital, Inc. acted as placement agent and received $65,000 in commissions and $26,000 representing a non-accountable expense fee. Lixte also issued to WestPark five year warrants to purchase up to 100,000 shares of the Compa...Commissions in Biological News
Britain's last Neanderthals were more sophisticated than we thought
...s south east England. The project now aims to prospect more widely across the region for similar sites. Barney Sloane, Head of Historic Environment commissions at English Heritage, said: "Sites such as this are extremely rare and a relatively little considered archaeological resource. Their remains sit at a k...Unmanned aircraft to study Southern California smog and its consequences
...g effects for the first time over California, and this data will likely help California reduce its global warming commitment. The California Energy commissions Public Interest Energy Research (PIER) program will employ CAPPS results in an analysis of the potential future economic and ecological consequences o...Proposal to step up cardiovascular disease research
... existing projects, and in particular the European Vascular Genomics Network (EVGN), which has been running since January 2004 as part of the European commissions FP6 framework research programme. EVGN has been promoting multidisciplinary interaction between 30 world class basic and clinical institutions in 11 E...Tiny fish can yield big clues to Delaware River health
...e new habitats for the bridle shiner. The results of the Academys studies, which will continue into 2008, will factor into the Delaware River Basin commissions flow management plans for the river. Bridle shiner prefer slow-moving, shallow waters that flow over beds of aquatic plants. The Upper Delaware River ...Commissions in Biological Technology
- Marks the first deployment of the system intended for hospitals and industrial facilities -
NORTHBROOK, Ill., and ANKLESHWAR, India, April 23 /PRNewswire/ -- PEAT
International, Inc., ("PEAT") a global leader in plasma-based waste
remediation solutions, announced toda...
... and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...
Exciton Technologies receives FDA approval to market exSALT(TM)
...sequently shown to be invalid or infringe the patents of others. Investors should consult the Company's quarterly and annual filings with the Canadian commissions for additional information on risks and uncertainties relating to the forward- looking statements. Investors are cautioned against placing undue relia...Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
...ounced the pricing of an underwritten offering of 7,248,936 shares of its common stock at a price of $3.14 per share. After underwriting discounts and commissions and estimated offering expenses, the company expects to receive net proceeds of approximately $21.2 million. All of the shares are being sold by Iden...... and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward...
Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results
...general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)
...rtainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue relian...Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters
... of $7.50 per share, resulting in expected net proceeds to the company of approximately $81.6 million (after payment of the underwriting discounts and commissions and estimated expenses). Leerink Swann LLC acted as sole book-running manager for the offering. Lazard Capital Markets LLC, Canaccord Adams ...Cell Therapeutics, Inc. Announces Exercise of Overallotment
...common stock, for aggregate gross proceeds of approximately $43.9 million. The net proceeds to the Company after deducting underwriting discounts and commissions and estimated offering expenses are expected to be approximately $40.3 million. Each warrant has an exercise price of $1.70 per warrant share...Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
...irstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today filed a preliminary short form base shelf prospectus with the securities commissions of British Columbia and Ontario and a corresponding shelf registration statement on Form S-3 with the United States Securities and Exchange Commission...Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
...954 additional shares of its common stock to cover overallotments, if any. The net proceeds to the Company after deducting underwriting discounts and commissions and estimated offering expenses, excluding any exercise of the underwriter's overallotment option, are expected to be approximately $35.0 million. ...Other TagsDentistryConstructionNepalAssamSensingUNICEFCadburyOther Contentschangechangechangechangechangechangechangechangechangechangestylestylestylestylestylestylestylesubcloningsubsubsubsubsuberinsubstitutionsubstitutionsubstitutionsubstitutionsubstitutionsubstitutionsubsidiarysubsidiarysubsidiarysubsidiarysubsidiarysubsidiarysupercoil
DentistryConstructionNepalNicaraguanVaryingAssamVariabilitySensingEvistaSandwichUNICEFCadburyAcademicsKannada
(Date:12/16/2009)... offer free nationwide confidential legal consultations for users of Paxil ... Birth Defects, Attempted Suicide, Suicide and Addiction Issues. Individuals suffering ... or go to the firm’s website at http://www.ennislaw.com ... ... (PRWEB) December 16, 2009 -- Bloomberg ...
(Date:12/15/2009)... The failure of the U.S. Senate to allow ... less the more effective direct bulk purchasing of ... how big industry controls the health reform debate, ... by Senator Dorgan (D-ND) was a relatively modest ... allow Medicare to directly negotiate discounts with drug ...
(Date:12/15/2009)... Palo Alto Networks(TM), the network security company, today ... Series next-generation firewalls for accurate threat prevention on ... control over applications such as peer-to-peer file sharing. ... with eight facilities on five campuses. The university ... of academic schools and institutions throughout Japan. It ...
(Date:12/15/2009)... fell in area where all couples of reproductive age ... (HealthDay News) -- The number of children born with ... might be CF mutation carriers increases, a new study ... an area of northeast Italy for many years. Since ... decline in the number of infants born with CF. ...
(Date:12/15/2009)... but not delivered ,, WASHINGTON, Dec. 15 ... to ensure that healthcare reform does not override ... insurance companies in 37 states. ,, Prostate cancer ... the population and individuals who are identifiable as ... who have a family history of prostate cancer. ...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2[0] Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil[1] Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog[1] Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University[0] Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis [1] Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform
(Date:12/15/2009)... WI, December 15, 2009 Economics, environmental impacts, ... factors that influence the overall success of an ... on the system, forcing individuals and social groups ... order to survive. , Experiential learning theory ... result of firsthand experiences. Such lessons are especially ...
(Date:12/15/2009)... and Ghent University in Flanders, Belgium have found an ... major cause of death in intensive care units. By ... mice with septic shock, researchers Anje Cauwels and Peter ... damage, while their chances of survival increased significantly. That,s ... that nitric oxide is responsible for the potentially lethal ...
(Date:12/15/2009)... German ., Despite the fact that ... cultures vary as to how space is encoded in ... terms such as ,left, right, front, back, to talk ... south, east, west, at all times for all scales: ... is an snake by your Northern leg". Whether not ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2Septic shock: Nitric oxide beneficial after all 2More than a jump to the left 2Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 61920 1Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 61920 2Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 61920 3Arcadia Resources Announces Closing of 2411 1 Million Financing 61915 1Arcadia Resources Announces Closing of 2411 1 Million Financing 61915 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 14938 1Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 14938 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |